Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,071,070
in 6 filings, $11.0M under 10b5-1 plans

Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-26 Matis Louis Chief Development Officer Grant or award · Stock Option (Right to Buy) +96,500 96,500
2018-02-20 Matis Louis Chief Development Officer Grant or award · Stock Options (Right to buy) +100,000 100,000
2017-02-23 Matis Louis Grant or award · Stock option (Right to buy) +145,000 145,000
2016-06-14 Matis Louis SVP, Chief Development Officer Purchase +7,915 $1.71 $14K 10,000
2016-06-13 Matis Louis SVP, Chief Development Officer Purchase +2,085 $1.68 $4K 2,085
2015-08-17 Matis Louis SVP, Chief Development Officer Grant or award · Common Stock +500,000 500,000

Page 1 of 1 · 6 trades